Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Cancer Trials Ireland
Cancer Trials Ireland
Genmab
M.D. Anderson Cancer Center
Genmab
Accent Therapeutics
Pheon Therapeutics
M.D. Anderson Cancer Center
Seagen Inc.
Fusion Pharmaceuticals Inc.
Fudan University
Blueprint Medicines Corporation
Alaunos Therapeutics
Artios Pharma Ltd
Tempus AI
Incyte Corporation
Virginia Commonwealth University
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Pfizer
Bio-Thera Solutions
University Health Network, Toronto
Numab Therapeutics AG
NuCana plc
Hutchmed
Lyell Immunopharma, Inc.
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Pfizer
Pfizer
Stanford University
Black Diamond Therapeutics, Inc.
University of Oklahoma
Columbia University
Ohio State University Comprehensive Cancer Center
Seagen Inc.
Seagen Inc.
Deciphera Pharmaceuticals, LLC
Fox Chase Cancer Center
Aminex Therapeutics, Inc.
Five Prime Therapeutics, Inc.
Elucida Oncology
Nurix Therapeutics, Inc.
Henry Ford Health System
Haihe Biopharma Co., Ltd.
University of Kentucky
UNC Lineberger Comprehensive Cancer Center
Sunnybrook Health Sciences Centre
Stanford University
pharmaand GmbH
Fate Therapeutics